BRIGHTSPRING HEALTH SERVICES (BTSG) Stock Fundamental Analysis
USA - NASDAQ:BTSG - US10950A1060 - Common Stock
27.31 USD
+0.06 (+0.22%)
27.31 USD
0 (0%)
Overall BTSG gets a fundamental rating of 4 out of 10. We evaluated BTSG against 101 industry peers in the Health Care Providers & Services industry. BTSG has an average financial health and profitability rating. BTSG is not priced too expensively while it is growing strongly. Keep and eye on this one!
1. Profitability
1.1 Basic Checks
BTSG had positive earnings in the past year.
BTSG had a positive operating cash flow in the past year.
In multiple years BTSG reported negative net income over the last 5 years.
BTSG had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
BTSG's Return On Assets of 1.10% is in line compared to the rest of the industry. BTSG outperforms 52.48% of its industry peers.
BTSG has a Return On Equity (3.76%) which is in line with its industry peers.
The Return On Invested Capital of BTSG (4.19%) is comparable to the rest of the industry.
BTSG had an Average Return On Invested Capital over the past 3 years of 3.45%. This is significantly below the industry average of 9.19%.
The last Return On Invested Capital (4.19%) for BTSG is above the 3 year average (3.45%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.1% | ||
| ROE | 3.76% | ||
| ROIC | 4.19% |
ROA(3y)-1.36%
ROA(5y)-0.55%
ROE(3y)-11.56%
ROE(5y)-5.06%
ROIC(3y)3.45%
ROIC(5y)3.56%
1.3 Margins
BTSG has a Profit Margin of 0.55%. This is comparable to the rest of the industry: BTSG outperforms 50.49% of its industry peers.
BTSG has a Operating Margin of 1.96%. This is comparable to the rest of the industry: BTSG outperforms 49.51% of its industry peers.
BTSG's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 12.88%, BTSG is doing worse than 67.33% of the companies in the same industry.
In the last couple of years the Gross Margin of BTSG has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 1.96% | ||
| PM (TTM) | 0.55% | ||
| GM | 12.88% |
OM growth 3Y-19.38%
OM growth 5Y5.54%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.88%
GM growth 5Y-5.21%
2. Health
2.1 Basic Checks
BTSG has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
BTSG has more shares outstanding than it did 1 year ago.
The number of shares outstanding for BTSG has been increased compared to 5 years ago.
The debt/assets ratio for BTSG has been reduced compared to a year ago.
2.2 Solvency
BTSG has an Altman-Z score of 3.03. This indicates that BTSG is financially healthy and has little risk of bankruptcy at the moment.
BTSG has a Altman-Z score of 3.03. This is in the better half of the industry: BTSG outperforms 61.39% of its industry peers.
BTSG has a debt to FCF ratio of 13.29. This is a negative value and a sign of low solvency as BTSG would need 13.29 years to pay back of all of its debts.
BTSG's Debt to FCF ratio of 13.29 is in line compared to the rest of the industry. BTSG outperforms 46.53% of its industry peers.
A Debt/Equity ratio of 1.43 is on the high side and indicates that BTSG has dependencies on debt financing.
The Debt to Equity ratio of BTSG (1.43) is worse than 66.34% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.43 | ||
| Debt/FCF | 13.29 | ||
| Altman-Z | 3.03 |
ROIC/WACC0.47
WACC8.83%
2.3 Liquidity
A Current Ratio of 1.76 indicates that BTSG should not have too much problems paying its short term obligations.
BTSG's Current ratio of 1.76 is fine compared to the rest of the industry. BTSG outperforms 63.37% of its industry peers.
BTSG has a Quick Ratio of 1.34. This is a normal value and indicates that BTSG is financially healthy and should not expect problems in meeting its short term obligations.
BTSG has a Quick ratio (1.34) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.76 | ||
| Quick Ratio | 1.34 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 130.29% over the past year.
BTSG shows a strong growth in Revenue. In the last year, the Revenue has grown by 20.60%.
The Revenue has been growing by 20.01% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)130.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%120%
Revenue 1Y (TTM)20.6%
Revenue growth 3Y18.93%
Revenue growth 5Y20.01%
Sales Q2Q%15.29%
3.2 Future
BTSG is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 38.52% yearly.
The Revenue is expected to grow by 12.46% on average over the next years. This is quite good.
EPS Next Y59.46%
EPS Next 2Y45.4%
EPS Next 3Y36.47%
EPS Next 5Y38.52%
Revenue Next Year11.36%
Revenue Next 2Y11.85%
Revenue Next 3Y11.89%
Revenue Next 5Y12.46%
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 36.91, BTSG can be considered very expensive at the moment.
BTSG's Price/Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Earnings ratio of 27.38, BTSG is valued a bit more expensive.
BTSG is valuated rather expensively with a Price/Forward Earnings ratio of 23.49.
The rest of the industry has a similar Price/Forward Earnings ratio as BTSG.
When comparing the Price/Forward Earnings ratio of BTSG to the average of the S&P500 Index (22.86), we can say BTSG is valued inline with the index average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 36.91 | ||
| Fwd PE | 23.49 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as BTSG.
BTSG's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 25.31 | ||
| EV/EBITDA | 17.21 |
4.3 Compensation for Growth
BTSG's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
BTSG's earnings are expected to grow with 36.47% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.62
PEG (5Y)N/A
EPS Next 2Y45.4%
EPS Next 3Y36.47%
5. Dividend
5.1 Amount
No dividends for BTSG!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
27.31
+0.06 (+0.22%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners55.39%
Inst Owner Change2.79%
Ins Owners2.61%
Ins Owner Change-4.37%
Market Cap4.84B
Analysts84.21
Price Target30.01 (9.89%)
Short Float %16.85%
Short Ratio6.59
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)61.63%
Min EPS beat(2)26.26%
Max EPS beat(2)97.01%
EPS beat(4)2
Avg EPS beat(4)20.64%
Min EPS beat(4)-38.02%
Max EPS beat(4)97.01%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)3.05%
Min Revenue beat(2)2.86%
Max Revenue beat(2)3.24%
Revenue beat(4)3
Avg Revenue beat(4)2.58%
Min Revenue beat(4)-0.62%
Max Revenue beat(4)4.83%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.62%
PT rev (3m)9.6%
EPS NQ rev (1m)10%
EPS NQ rev (3m)18.17%
EPS NY rev (1m)0%
EPS NY rev (3m)3.31%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.31%
Revenue NY rev (1m)-0.01%
Revenue NY rev (3m)1.5%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 36.91 | ||
| Fwd PE | 23.49 | ||
| P/S | 0.4 | ||
| P/FCF | 25.31 | ||
| P/OCF | 18.02 | ||
| P/B | 2.78 | ||
| P/tB | N/A | ||
| EV/EBITDA | 17.21 |
EPS(TTM)0.74
EY2.71%
EPS(NY)1.16
Fwd EY4.26%
FCF(TTM)1.08
FCFY3.95%
OCF(TTM)1.52
OCFY5.55%
SpS67.66
BVpS9.84
TBVpS-6.61
PEG (NY)0.62
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.1% | ||
| ROE | 3.76% | ||
| ROCE | 5.3% | ||
| ROIC | 4.19% | ||
| ROICexc | 4.26% | ||
| ROICexgc | 12.79% | ||
| OM | 1.96% | ||
| PM (TTM) | 0.55% | ||
| GM | 12.88% | ||
| FCFM | 1.59% |
ROA(3y)-1.36%
ROA(5y)-0.55%
ROE(3y)-11.56%
ROE(5y)-5.06%
ROIC(3y)3.45%
ROIC(5y)3.56%
ROICexc(3y)3.47%
ROICexc(5y)3.63%
ROICexgc(3y)17.05%
ROICexgc(5y)18.21%
ROCE(3y)4.37%
ROCE(5y)4.5%
ROICexcg growth 3Y-9.4%
ROICexcg growth 5Y19.06%
ROICexc growth 3Y-3.14%
ROICexc growth 5Y18.48%
OM growth 3Y-19.38%
OM growth 5Y5.54%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.88%
GM growth 5Y-5.21%
F-Score7
Asset Turnover2.02
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.43 | ||
| Debt/FCF | 13.29 | ||
| Debt/EBITDA | 5.85 | ||
| Cap/Depr | 40.85% | ||
| Cap/Sales | 0.65% | ||
| Interest Coverage | 1.2 | ||
| Cash Conversion | 63.22% | ||
| Profit Quality | 291.7% | ||
| Current Ratio | 1.76 | ||
| Quick Ratio | 1.34 | ||
| Altman-Z | 3.03 |
F-Score7
WACC8.83%
ROIC/WACC0.47
Cap/Depr(3y)36.76%
Cap/Depr(5y)33.73%
Cap/Sales(3y)0.82%
Cap/Sales(5y)0.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)130.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%120%
EPS Next Y59.46%
EPS Next 2Y45.4%
EPS Next 3Y36.47%
EPS Next 5Y38.52%
Revenue 1Y (TTM)20.6%
Revenue growth 3Y18.93%
Revenue growth 5Y20.01%
Sales Q2Q%15.29%
Revenue Next Year11.36%
Revenue Next 2Y11.85%
Revenue Next 3Y11.89%
Revenue Next 5Y12.46%
EBIT growth 1Y172.04%
EBIT growth 3Y-4.13%
EBIT growth 5Y26.66%
EBIT Next Year59.04%
EBIT Next 3Y24.94%
EBIT Next 5Y28%
FCF growth 1Y186.65%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y284.83%
OCF growth 3Y-55.52%
OCF growth 5Y-26.51%